Research and Markets: Nasopharyngitis (Common Cold) Pipeline Review, H2 2015 - 5 Companies & 11 Drug Profiles
September 04 2015 - 8:24AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/9rn677/nasopharyngitis)
has announced the addition of the "Nasopharyngitis (Common Cold) -
Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the
therapeutic development for Nasopharyngitis (Common Cold), complete
with comparative analysis at various stages, therapeutics
assessment by drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type, along with latest updates,
and featured news and press releases. It also reviews key players
involved in the therapeutic development for Nasopharyngitis (Common
Cold) and special features on late-stage and discontinued
projects.
The report enhances decision making capabilities and helps to
create effective counter strategies to gain competitive advantage.
It strengthens R&D pipelines by identifying new targets and
MOAs to produce first-in-class and best-in-class products.
Companies Involved in Therapeutics Development
- Charleston Laboratories, Inc.
- Cocrystal Pharma, Inc.
- Neos Therapeutics, Inc.
- Orbis Biosciences, Inc.
- Vernalis Plc
Drug Profiles
- (chlorpheniramine maleate + codeine)
- Antibody to Target TRIM-21 for Gastrointestinal and Ear Nose
Throat Disorders
- CCP-05
- CCP-06
- CCP-07
- CCP-08
- CLAT-313
- guaifenesin ER
- Small Molecule for Cough and Cold
- Small Molecule to Inhibit MAPK13 for Asthma and Cold
- Small Molecules to Inhibit RNA Dependent RNA Polymerase for
Common Cold
For more information visit
http://www.researchandmarkets.com/research/9rn677/nasopharyngitis
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150904005288/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Pharmaceuticals